Daniel Joseph OConnell - President and CEO, Director at Acumen Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ABOS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Daniel Joseph OConnell - trading volume in the past year for Acumen Pharmaceuticals, Inc.

Holdings reported by Daniel Joseph OConnell for Acumen Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 502K $1.74M $3.47 Jan 19, 2024 Direct
Employee Stock Option (right to buy) 602K Jan 2, 2024 Direct Common Stock

Transactions reported by Daniel Joseph OConnell for Acumen Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.